These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of Lactobacillus reuteri NCIMB 30351 drops on symptoms of infantile functional gastrointestinal disorders and gut microbiota in early infants: Results from a randomized, placebo-controlled clinical trial. Tyrsin OY; Tyrsin DY; Nemenov DG; Ruzov AS; Odintsova VE; Koshechkin SI; D Amico L Eur J Pediatr; 2024 May; 183(5):2311-2324. PubMed ID: 38427038 [TBL] [Abstract][Full Text] [Related]
3. Peng Y; Ma Y; Luo Z; Jiang Y; Xu Z; Yu R Front Cell Infect Microbiol; 2023; 13():1254198. PubMed ID: 37662007 [TBL] [Abstract][Full Text] [Related]
4. Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial. Ismail NI; Nawawi KNM; Hsin DCC; Hao KW; Mahmood NRKN; Chearn GLC; Wong Z; Tamil AM; Joseph H; Raja Ali RA Helicobacter; 2023 Dec; 28(6):e13017. PubMed ID: 37614081 [TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial. Kubota M; Ito K; Tomimoto K; Kanazaki M; Tsukiyama K; Kubota A; Kuroki H; Fujita M; Vandenplas Y Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952280 [TBL] [Abstract][Full Text] [Related]
6. Use of Dargenio VN; Cristofori F; Dargenio C; Giordano P; Indrio F; Celano G; Francavilla R Benef Microbes; 2022 Aug; 13(3):221-242. PubMed ID: 35212258 [TBL] [Abstract][Full Text] [Related]
7. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Urbańska M; Szajewska H Eur J Pediatr; 2014 Oct; 173(10):1327-37. PubMed ID: 24819885 [TBL] [Abstract][Full Text] [Related]
8. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. Dinleyici EC; Dalgic N; Guven S; Metin O; Yasa O; Kurugol Z; Turel O; Tanir G; Yazar AS; Arica V; Sancar M; Karbuz A; Eren M; Ozen M; Kara A; Vandenplas Y J Pediatr (Rio J); 2015; 91(4):392-6. PubMed ID: 25986615 [TBL] [Abstract][Full Text] [Related]
9. Randomised double blind placebo controlled trial on Lactobacillus reuteri DSM 17938: improvement in symptoms and bowel habit in functional constipation. Riezzo G; Orlando A; D'Attoma B; Linsalata M; Martulli M; Russo F Benef Microbes; 2018 Jan; 9(1):51-60. PubMed ID: 29022390 [TBL] [Abstract][Full Text] [Related]
10. Probiotics in Functional Gastrointestinal Disorders. Hojsak I Adv Exp Med Biol; 2024; 1449():157-174. PubMed ID: 39060737 [TBL] [Abstract][Full Text] [Related]
11. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis. Piccioni A; Franza L; Vaccaro V; Saviano A; Zanza C; Candelli M; Covino M; Franceschi F; Ojetti V Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441008 [TBL] [Abstract][Full Text] [Related]
12. Lactobacillus reuteri derived from horse alleviates Escherichia coli-induced diarrhea by modulating gut microbiota. Wang D; Zeng J; Wujin C; Ullah Q; Su Z Microb Pathog; 2024 Mar; 188():106541. PubMed ID: 38224920 [TBL] [Abstract][Full Text] [Related]
13. The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial. Wegner A; Banaszkiewicz A; Kierkus J; Landowski P; Korlatowicz-Bilar A; Wiecek S; Kwiecien J; Gawronska A; Dembinski L; Czaja-Bulsa G; Socha P Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):494-500. PubMed ID: 29650440 [TBL] [Abstract][Full Text] [Related]
14. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. Ojetti V; Ianiro G; Tortora A; D'Angelo G; Di Rienzo TA; Bibbò S; Migneco A; Gasbarrini A J Gastrointestin Liver Dis; 2014 Dec; 23(4):387-91. PubMed ID: 25531996 [TBL] [Abstract][Full Text] [Related]
16. Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. Ojetti V; Petruzziello C; Migneco A; Gnarra M; Gasbarrini A; Franceschi F Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1702-1708. PubMed ID: 28429333 [TBL] [Abstract][Full Text] [Related]
17. Probiotics in Functional Gastrointestinal Disorders. Hojsak I Adv Exp Med Biol; 2019; 1125():121-137. PubMed ID: 30578460 [TBL] [Abstract][Full Text] [Related]
18. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Cruchet S; Furnes R; Maruy A; Hebel E; Palacios J; Medina F; Ramirez N; Orsi M; Rondon L; Sdepanian V; Xóchihua L; Ybarra M; Zablah RA Paediatr Drugs; 2015 Jun; 17(3):199-216. PubMed ID: 25799959 [TBL] [Abstract][Full Text] [Related]
19. "The role of L. reuteri DSM17938 in nutritional recovery and treatment of constipation in children and adolescents with anorexia nervosa - a randomized, double blind, placebo controlled study". Žaja O; Fiolić M; Ćuk MC; Tiljak MK Clin Nutr ESPEN; 2021 Dec; 46():47-53. PubMed ID: 34857236 [TBL] [Abstract][Full Text] [Related]
20. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Dinleyici EC; ; Vandenplas Y Acta Paediatr; 2014 Jul; 103(7):e300-5. PubMed ID: 24579935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]